CIRIT The Catalonia BioCluster La BioRegió de Catalunya Marta Aymerich, MD, PhD Director...
-
Upload
jeffrey-tyler -
Category
Documents
-
view
215 -
download
0
Transcript of CIRIT The Catalonia BioCluster La BioRegió de Catalunya Marta Aymerich, MD, PhD Director...
CIRIT
The Catalonia BioClusterLa BioRegió de Catalunya
Marta Aymerich, MD, PhDDirector
Interministerial Council for Research and Technological
InnovationGovernment of Catalonia
CIRITResearch & Innovation Plan 2005-
2008
Catalonia R&D, 2008
Mission:To position Catalonia among the leading research and innovation countries in Europe involving public and private agents
CIRITR&D expenditure by
sector
Businesses66,3%
Higher Education24,3%
Non-profit entities0,3%
Public Administration 9,1%
Businesses Non-profit Public Admin Higher Ed
PUBLIC SECTOR (1/3)PRIVATE SECTOR (2/3)
2003 (INE)
CIRIT
Technology & Science Parks
UNIVERSITY
BUSINESS
Administration
RESEARCH INNOVATION
Res
earc
h
Cen
ters
& H
osp
ital
s
Demand
Offer
Science&Technology push
Market pull
Knowledge society relations
CIRITCatalan scientific
productionCatalonia has traditionally been strong in biomedicine and life sciences, with extensive scientific production
Jordi Camí 1, 2, Eduard Suñén1 i Raül Isaac Méndez-Vásquez1
Institut Municipal d’Investigació Mèdica (IMIM)1 i Universitat Pompeu Fabra2 , Barcelona. Estudio realizado a petición del CIRIT, abril 2004 a partir de bases de datos ISI. Documentos citables
CIRITCritical factors for biocluster
development1. Strong science base2. Entrepreneurial culture3. Growing company base4. Ability to attract key staff5. Skilled workforce6. Availability of finance7. Premises and infrastructure8. Business support services and large
companies in related industries9. Effective networks10.Supportive policy environment
Biotechnology Clusters; Lord Sainsbury, Science Minister UK, 1999
CIRIT
- Abat Oliva University
Good quality Higher Ed & Research facilities
12 Universities 30 advanced research centres 13 science parks:
3 biomedical, 3 agro-food Synchrotron Light Source
This new laboratory will be operative at the end of 2008, with 125 people providing services to more than 150 research groups and to nearly 750 researchers. It will be of use to the scientific community of southern Europe
Supercomputer Center (Mare Nostrum) Fourth supercomputer of the
world. It started its activity at the beginning of this year (2005)
CIRITAbility to attract key staff
ICREA programAim: to attract high level researchers
(overseas)4th year running: 100 senior researchers70% are from abroad2004 > 500 applications for 25 senior research
positions
ICREA biggest percentage: biomedical sciences (31%)
CIRITCatalonia BioCluster:
Key facts
2 international business schools (IESE, ESADE) Network of technological springboards
(entrepreneurial centers linked to main universities and business schools; spin-off incubation)
46% of the pharmaceutical companies in Spain are located in Catalonia, accounting for 60% of the production
Strong chemistry sector (fine chemistry, green chemistry) 38% of Spanish medical devices companies 40 biotech companies, 20 of them as core sector
Entrepreneurial character
Innovative national industry
CIRIT
Ernst & Young, 2003
World biotech companies
CIRIT
During 2004, the Catalan Government together with public and private bodies involved in the sector established a work team to develop a preliminary project for the Catalonia BioCluster
Vision
with a clear impact on the
The existence and enhancing of a biomed and biotech based business activity of international reference in Catalonia, generation of added value and more and better welfare
Catalonia BioCluster
CIRITSupportive policy environment
A. Castells C. Solà J. Bargalló M. Geli JM RañéM. Economy M. ResearchPrime Minister M. Health M. Occup &
Industry
Public presentation of starting organization of the Catalan Biocluster
17th November 2004
CIRIT
General Objectives (10)
MISSION To position Catalonia among the leading research and innovation countries in Europe by
means of the implementation of an integrated public policy, involving public and private agents working in conjunction, which will foster the development of a society based on knowledgeand entrepreneurship, and which will ultimately achieve sustainable economic development
and ensure social wellbeing and cohesion.
Transverse Measures
Research Support ProgramResearch Staff ProgramResearch Centers and Infrastructures Programme • Technology and Knowledge Transfer Support Program Innovation Support ProgramFinancial Support Program
Complementary MeasuresMobility, Cooperation and International ProgramProgram for Promoting and Communicating Science and Technology Entrepreneurial Support Program
Initiatives to Foster Innovation in Government Ministries
Program for Coordinating and Obtaining State and EU Resources
Programs 2005 – 2008
Priority Areas and Sectoral StrategiesPriority research linesSectoral and technology strategies
Research & Innovation Plan 2005-2008
Priority research lines
To foster all areas of science and technology, and in particular, to foster fundamental research while applying criteria of quality and excellence
Biomedicine and the health sciences
ICT engineeringAgro-alimentary sciences and
technologySocial and cultural developmentSustainable development and the
environment. Cross-disciplinary area:
nanoscience & nanotech
CIRIT
VIENNAVIENNA
# 1# 3
# 2
# 4PARISPARIS
BERLINBERLIN
#3EuroBioNorth#4EuroBioEast
#1EuroBioWest#2EuroBioSouth
EDINBURGHEDINBURGH
LILLELILLE
LOXBRIDGELOXBRIDGE
WARSAWWARSAW
STOCKHOLMSTOCKHOLM
COPENHAGENCOPENHAGEN
BRUSSELSBRUSSELS
AMSTERDAMAMSTERDAM
PRAGUEPRAGUE
BUDAPESTBUDAPEST
HAMBURGHAMBURG
HANNOVERHANNOVER
FRANKFURTFRANKFURTKOLNKOLN
DUBLINDUBLIN
BARCELONABARCELONA
LYONLYON
GRENOBLEGRENOBLEMILANMILAN
GENEVAGENEVA LAUSANNELAUSANNE
ZURICHZURICHBASELBASEL MUNICHMUNICH
STUTTGARTSTUTTGARTSTRASBOURGSTRASBOURG
HEIDELBERGHEIDELBERG
MONTPELLIERMONTPELLIERMARSEILLEMARSEILLE
SZEGEDSZEGED
MAASTRICHTMAASTRICHT
VIENNAVIENNA
# 1# 3
# 2
# 4PARISPARIS
BERLINBERLIN
#3EuroBioNorth#4EuroBioEast
#1EuroBioWest#2EuroBioSouth
EDINBURGHEDINBURGH
LILLELILLE
LOXBRIDGELOXBRIDGE
WARSAWWARSAW
STOCKHOLMSTOCKHOLM
COPENHAGENCOPENHAGEN
BRUSSELSBRUSSELS
AMSTERDAMAMSTERDAM
PRAGUEPRAGUE
BUDAPESTBUDAPEST
HAMBURGHAMBURG
HANNOVERHANNOVER
FRANKFURTFRANKFURTKOLNKOLN
DUBLINDUBLIN
BARCELONABARCELONA
LYONLYON
GRENOBLEGRENOBLEMILANMILAN
GENEVAGENEVA LAUSANNELAUSANNE
ZURICHZURICHBASELBASEL MUNICHMUNICH
STUTTGARTSTUTTGARTSTRASBOURGSTRASBOURG
HEIDELBERGHEIDELBERG
MONTPELLIERMONTPELLIERMARSEILLEMARSEILLE
SZEGEDSZEGED
MAASTRICHTMAASTRICHT
VIENNAVIENNA
# 1# 3
# 2
# 4PARISPARIS
BERLINBERLIN
#3EuroBioNorth#4EuroBioEast
#1EuroBioWest#2EuroBioSouth
EDINBURGHEDINBURGH
LILLELILLE
LOXBRIDGELOXBRIDGE
WARSAWWARSAW
STOCKHOLMSTOCKHOLM
COPENHAGENCOPENHAGEN
BRUSSELSBRUSSELS
AMSTERDAMAMSTERDAM
PRAGUEPRAGUE
BUDAPESTBUDAPEST
HAMBURGHAMBURG
HANNOVERHANNOVER
FRANKFURTFRANKFURTKOLNKOLN
DUBLINDUBLIN
BARCELONABARCELONA
LYONLYON
GRENOBLEGRENOBLEMILANMILAN
GENEVAGENEVA LAUSANNELAUSANNE
ZURICHZURICHBASELBASEL MUNICHMUNICH
STUTTGARTSTUTTGARTSTRASBOURGSTRASBOURG
HEIDELBERGHEIDELBERG
MONTPELLIERMONTPELLIERMARSEILLEMARSEILLE
SZEGEDSZEGED
MAASTRICHTMAASTRICHT
VIENNAVIENNA
# 3# 1
# 2
# 4PARISPARIS
BERLINBERLIN
#3EuroBioWest#4EuroBioEast
#1Scanbalt (nord)#2EuroBioSouth
EDINBURGHEDINBURGH
LILLELILLE
LOXBRIDGELOXBRIDGE
WARSAWWARSAW
STOCKHOLMSTOCKHOLM
COPENHAGENCOPENHAGEN
BRUSSELSBRUSSELS
AMSTERDAMAMSTERDAM
PRAGUEPRAGUE
BUDAPESTBUDAPEST
HAMBURGHAMBURG
HANNOVERHANNOVER
FRANKFURTFRANKFURTKOLNKOLN
DUBLINDUBLIN
BARCELONABARCELONA
LYONLYON
GRENOBLEGRENOBLEMILANMILAN
GENEVAGENEVA LAUSANNELAUSANNE
ZURICHZURICHBASELBASEL MUNICHMUNICH
STUTTGARTSTUTTGARTSTRASBOURGSTRASBOURG
HEIDELBERGHEIDELBERG
MONTPELLIERMONTPELLIERMARSEILLEMARSEILLE
SZEGEDSZEGED
MAASTRICHTMAASTRICHT
Prof. Carles Solà, Minister of
Universities, Research and
Information Society of Catalonia signing
the agreement
EuroBioCluster South